Total Payments
$474,851
2024 Payments
$31,278
Companies
67
Transactions
1,583
Medicare Patients
4,032
Medicare Billing
$494,715
Payment Breakdown by Category
Other$400,760 (84.4%)
Food & Beverage$31,839 (6.7%)
Travel$25,311 (5.3%)
Consulting$16,457 (3.5%)
Education$484.44 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $400,760 | 214 | 84.4% |
| Food and Beverage | $31,839 | 1,210 | 6.7% |
| Travel and Lodging | $25,311 | 137 | 5.3% |
| Consulting Fee | $16,457 | 10 | 3.5% |
| Education | $484.44 | 12 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $144,141 | 312 | $0 (2024) |
| GlaxoSmithKline, LLC. | $114,064 | 261 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $58,746 | 171 | $0 (2023) |
| JAZZ PHARMACEUTICALS INC. | $43,535 | 122 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $24,991 | 58 | $0 (2024) |
| Circassia Pharmaceuticals Inc | $20,088 | 25 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $14,339 | 58 | $0 (2020) |
| PORTOLA PHARMACEUTICALS, INC. | $9,988 | 22 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $6,623 | 14 | $0 (2017) |
| Resmed Corp | $6,430 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $31,278 | 89 | AstraZeneca Pharmaceuticals LP ($30,233) |
| 2023 | $40,136 | 153 | GlaxoSmithKline, LLC. ($11,595) |
| 2022 | $83,887 | 206 | GlaxoSmithKline, LLC. ($40,007) |
| 2021 | $62,306 | 175 | AstraZeneca Pharmaceuticals LP ($26,412) |
| 2020 | $51,814 | 216 | AstraZeneca Pharmaceuticals LP ($24,515) |
| 2019 | $85,709 | 270 | Boehringer Ingelheim Pharmaceuticals, Inc. ($26,304) |
| 2018 | $61,217 | 236 | Boehringer Ingelheim Pharmaceuticals, Inc. ($16,053) |
| 2017 | $58,504 | 238 | Jazz Pharmaceuticals Inc. ($18,578) |
All Payment Transactions
1,583 individual payment records from CMS Open Payments — Page 1 of 64
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $1.99 | General |
| Category: NEUROLOGY | ||||||
| 12/10/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: NEUROLOGY | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $123.97 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $30.82 | General |
| Category: Respiratory | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Respiratory | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: NEUROLOGY | ||||||
| 11/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $129.65 | General |
| Category: Immunology | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $120.63 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $25.46 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $7.52 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $133.74 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: RESPIRATORY | ||||||
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Respiratory | ||||||
| 10/14/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $100.58 | General |
| Category: NEUROLOGY | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $121.17 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 826 | 1,292 | $229,885 | $109,495 |
| 2022 | 17 | 915 | 1,353 | $310,825 | $123,004 |
| 2021 | 17 | 984 | 1,469 | $351,730 | $132,597 |
| 2020 | 21 | 1,307 | 1,866 | $403,593 | $129,619 |
Total Patients
4,032
Total Services
5,980
Medicare Billing
$494,715
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 59 | 167 | $57,290 | $26,490 | 46.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 176 | 255 | $48,705 | $22,741 | 46.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 70 | 186 | $28,046 | $16,685 | 59.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 43 | 96 | $25,632 | $12,279 | 47.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 62 | 139 | $14,456 | $8,300 | 57.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 37 | 37 | $10,767 | $4,330 | 40.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 36 | 36 | $7,128 | $3,421 | 48.0% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 39 | 39 | $7,644 | $3,339 | 43.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $6,175 | $2,995 | 48.5% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 24 | 25 | $5,075 | $2,269 | 44.7% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2023 | 79 | 79 | $7,821 | $2,172 | 27.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 27 | $3,618 | $1,641 | 45.4% |
| 95976 | Electronic analysis of neurostimulator generator with simple cranial nerve stimulator programming | Office | 2023 | 21 | 45 | $3,645 | $1,273 | 34.9% |
| 95977 | Electronic analysis of implanted neurostimulator generator with complex cranial nerve stimulator programming | Office | 2023 | 11 | 11 | $1,188 | $404.70 | 34.1% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 20 | 21 | $756.00 | $355.95 | 47.1% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 33 | 35 | $700.00 | $310.08 | 44.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 32 | 34 | $714.00 | $258.06 | 36.1% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 33 | 35 | $525.00 | $230.52 | 43.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 83 | 248 | $128,652 | $42,891 | 33.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 180 | 263 | $50,233 | $24,962 | 49.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 65 | 149 | $26,353 | $11,852 | 45.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 30 | 58 | $15,486 | $8,175 | 52.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 79 | 139 | $15,431 | $7,720 | 50.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 38 | 39 | $11,349 | $5,598 | 49.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 45 | 48 | $10,842 | $5,008 | 46.2% |
About Dr. Junaid Malik, MD
Dr. Junaid Malik, MD is a Critical Care Medicine healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598859852.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Junaid Malik, MD has received a total of $474,851 in payments from pharmaceutical and medical device companies, with $31,278 received in 2024. These payments were reported across 1,583 transactions from 67 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($400,760).
As a Medicare-enrolled provider, Malik has provided services to 4,032 Medicare beneficiaries, totaling 5,980 services with total Medicare billing of $494,715. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Orlando, FL
- Active Since 10/03/2006
- Last Updated 10/29/2024
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1598859852
Products in Payments
- BREZTRI (Drug) $66,293
- TRELEGY ELLIPTA (Drug) $48,065
- NUCALA (Biological) $34,652
- FASENRA (Drug) $31,943
- Xyrem (Drug) $30,112
- DUPIXENT (Biological) $25,554
- BREZTRI AEROSPHERE (Drug) $20,872
- NIOX VERO DEVICE (Device) $20,039
- FASENRA (Biological) $13,635
- TEZSPIRE (Biological) $12,102
- XYREM (Drug) $11,278
- ANORO ELLIPTA (Drug) $11,247
- BEVYXXA (Drug) $9,911
- LONHALA MAGNAIR (Drug) $8,264
- XARELTO (Drug) $6,623
- AIRSENSE (Device) $6,415
- UTIBRON (Drug) $5,966
- ANORO (Drug) $3,935
- Yupelri (Drug) $3,680
- GLASSIA (Biological) $3,596
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Orlando
Louis Guzzi, Md, MD
Critical Care Medicine — Payments: $762,875
Critical Care Medicine $762,875
Dr. Omid Zad, Md, MD
Critical Care Medicine — Payments: $334,047
Critical Care Medicine $334,047
Debabrata Bandyopadhyay, Md, MD
Critical Care Medicine — Payments: $307,159
Critical Care Medicine $307,159
Charles Hunley, M.d, M.D
Critical Care Medicine — Payments: $254,349
Critical Care Medicine $254,349
Dr. Dmitriy Zubkus, M.d, M.D
Critical Care Medicine — Payments: $62,293
Critical Care Medicine $62,293
Hammad Bhatti, M.d.,, M.D.,
Critical Care Medicine — Payments: $51,853
Critical Care Medicine $51,853